Search PubMed⌕ Search

Biomedical subjects

M Morimoto

Publications and source records attributed to M Morimoto.

At least 271 records · Page 15Linked to original sources
PubMed1988

Suppressive effect of ulinastatin on plasma fibronectin depression after cardiac surgery.

Plasma fibronectin, an opsonic glycoprotein, is known to modulate the reticuloendothelial phagocytic clearance of nonbacterial and, possibly, bacterial particulates. The decreased plasma fibronectin levels seen after cardiac surgery have been considered to derive mainly from opsonic consumption. In the present study, we demonstrated that the administration of ulinastatin, a human urinary trypsin inhibitor, to patients after cardiac surgery not only inhibited the postoperative depression of plasma fibronectin levels, but also maintained the plasma fibronectin level within the normal range. This effect apparently resulted from the inhibitory activity of ulinastatin on the proteolytic enzymes released after operation. This result suggests that the decreased plasma fibronectin level noted after cardiac surgery may derive mostly from excessive proteolytic enzymes. Our observation also indicates that the prophylactic administration of ulinastatin to patients undergoing major operations will result in a favorably functional reticuloendothelial phagocytic system.

Cardiac Surgical Procedures↗
PubMed1988

Partial resection of atrial septal aneurysm with multiple fenestrations--a case report.

Aneurysms of the interatrial septum are uncommon lesions that are often accompanied by other cardiac anomalies or systemic thrombosis. The authors report 1 case of atrial septum aneurysm that was diagnosed by two-dimensional contrast echocardiography. At surgery a membrane-like, fenestrated aneurysmal protrusion to the right atrium without thrombosis was seen. The atrial septum was closed without using an artificial patch after some of the aneurysm with fenestrations was resected.

Adult↗
PubMed1987

Projection from the pretectal nuclei to the dorsal lateral geniculate nucleus in the cat: a wheat germ agglutinin-horseradish peroxidase study.

To study the projection from the pretectum to the dorsal lateral geniculate nucleus (LGNd) in the cat, we used anterograde and retrograde transport of wheat germ agglutinin-horseradish peroxidase (WGA-HRP). Special attention was directed to the retinotopic maps of the pretectum and LGNd. Multiple restricted injections were made into different parts of the pretectum or LGNd. The pretectogeniculate pathway terminates mostly in the medial interlaminar nucleus (MIN) and layers A and A1, and to some extent in the lamina C within the ipsilateral LGNd. The lateral part of the nucleus of the optic tract (NTO) receives afferents from the superior retina, and the medial part of NTO and posterior pretectal nucleus (NPP) receives afferents from the inferior retina. There is no topographic organization in the retinal projection to the olivary pretectal nucleus (NOL). The lateral part of NTO projects ipsilaterally to the rostral portion of LGNd, which receives afferents from the superior retina. The medial part of NTO projects ipsilaterally to the caudal portion of LGNd, which receives afferents from the inferior retina. The NOL projects to all laminar parts of LGNd, ipsilaterally. The NPP projects largely to the ipsilateral MIN, which receives afferents from the pericentral and peripheral retina. These results suggest that similar parts of the retinotopic maps present in the pretectum and LGNd are connected.

Animals↗
PubMed1987

Hyperphagia and obesity in rats with bilateral ibotenic acid-induced lesions of the ventromedial hypothalamic nucleus.

Macro-electrophoretic applications of the cellular neurotoxin ibotenic acid into the ventromedial hypothalamic nucleus (VMH) resulted in hyperphagia and obesity in male rats. Histological examination showed a reduction in the number of neuronal VMH cell bodies with glial proliferation without evidence of non-specific damage. This supports the hypothesis that hyperphagia and obesity after VMH lesions are related to destruction of neurons intrinsic to the VMH.

Animals↗
PubMed1987

Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).

A novel antitumor antibiotic, 2a,3,4,5,6,6a,7,11b-octahydro-11-methoxy-12-methyl-3,6-imino-1H-2-oxa-11 c- azanaphth(1,2,3-cd)azulene-5-carboxylic acid monocitrate (quinocarmycin citrate; KW2152) was selected for investigation in a number of experimental tumor systems because of its efficacy against P388 leukemia. In the initial studies with P388 leukemia (i.p.-i.p.), KW2152 gave an increase in life span of greater than 80%. The activity was schedule dependent and daily administration was the most effective. KW2152 caused marginal activity against L1210 leukemia, B16 melanoma, and M5076 sarcoma. The effect on cultured cells suggested that KW2152 was not cross-resistant to Adriamycin (ADM) but was cross-resistant to mitomycin C (MMC); however, KW2152 caused prolongation of life span against mice bearing P388/ADM or P388/MMC. In tests against human tumors xenografted s.c. in nude mice, KW2152 significantly inhibited the growth of MX-1 mammary carcinoma with all tumors cured at i.v. doses of 4.4 mg/kg/day and p.o. doses of 26.2 mg/kg/day given daily for 7 days. KW2152 also inhibited distinct human gastric carcinomas, St-4 and St-15 tumors, and colon carcinoma Co-3 by daily administration for 7 days. Against St-4, KW2152 gave a treated versus control percentage of 27, compared to 52 for cis-diamminedichloroplatinum. Against Co-3, KW2152 was at least as effective as MMC, ADM, cis-diamminedichloroplatinum, and bleomycin, giving a treated versus control percentage of 18 at a dose of 8.6 mg/kg/day given daily for 7 days. KW2152 showed growth inhibitory activity against cultured murine tumors and human cells. The order of in vitro efficacy of KW2152 against murine tumors, P388 leukemia greater than L1210 leukemia, B16 melanoma, correlated with the order of the sensitivity on the i.p.-i.p. systems of these tumors. The 50% inhibitory concentrations against P388 leukemia cells were 5.3 X 10(-6) and 1.1 X 10(-7) M after 1 and 72 h exposure, respectively. KW2152 caused significant inhibition of RNA synthesis after a short time exposure. In P388 leukemia cells exposed for 1 h with KW2152, the 50% inhibitory concentration for RNA synthesis was 10(-5) M, 30-fold less than that for DNA synthesis. White blood cell depression or platelet depression was not significant after administration of the i.v. 10% lethal dose given daily for 7 days. Because of its good activity against human mammary tumor MX-1 and some effectiveness against other gastric and colon carcinomas and its water solubility, a novel antitumor antibiotic, KW2152, is being developed as a Phase I anticancer agent.

Animals↗
PubMed1987

Determination of kynurenine in serum by high-performance liquid chromatography after enzymatic conversion to 3-hydroxykynurenine.

A method for the determination of the physiological level of kynurenine in human serum based upon conversion of kynurenine to 3-hydroxykynurenine by enzymatic reaction with the mitochondrial fraction and NADPH and analysis by reversed-phase high-performance liquid chromatography with electrochemical detection is described. Tryptophan gave no interference. For one analysis, 0.2 ml of serum was sufficient, compared with the large volume (5.0 ml) required for other methods.

Chromatography, High Pressure Liquid↗
PubMed1987

Intramucosal distribution of the glossopharyngeal sensory fibers of cats.

In order to determine distribution of the sensory fibers of the glossopharyngeal nerve (IX) in the pharynx of cats, wheat germ agglutinin-horseradish peroxidase was injected into the superior and inferior ganglia of IX. Results were as follows: Labeled peripheral sensory nerve fibers in the pharynx were recognized ipsilaterally. The pharyngeal branch of IX innervated the nasopharyngeal mucosa at the level of the torus tubarius. The tonsillo-lingual branch was divided into four rami. The first ramus innervated the caudal one-third of the tongue and the vallate papillae. The second ramus innervated the palatine tonsil and the caudal half of the soft palate. The third ramus supplied a part of the radix linguae, the vallecula epiglottica and the lingual aspect of the epiglottis. The fourth ramus supplied the hypopharyngeal mucosa rostral to the middle level of the aryepiglottic fold.

Afferent Pathways↗
PubMed1987

Proton nuclear magnetic resonance study on the solution conformation of human epidermal growth factor.

This paper describes elucidation of the conformation of the human epidermal growth factor (hEGF) in an aqueous environment, using one- and two-dimensional proton nuclear magnetic resonance methods. The noted structural information obtained is that a rigid core structure is formed by the interplay of the three disulfide bridges and an antiparallel beta-sheet consisting of Val-19 to Glu-24 and Asp-27 to Asn-32. Furthermore, the hydrophobic amino acid residues of the long C-terminal segment fold back to interact locally with residues in the beta-sheet. It is suggested that the C-terminal residues play an inevitable role in the formation of the receptor-binding site.

Binding Sites↗
PubMed1987

Characterization of receptors for human recombinant interferon-gamma in human cells.

Highly purified human recombinant interferon-gamma (ReIFN-gamma) was radioiodinated with 125I-Bolton-Hunter reagent and used to characterize the receptor for ReIFN-gamma. 125I ReIFN-gamma specifically and saturably bound four human cells tested, FL, WISH, Daudi, and HL-60, which were reported to have ReIFN-gamma binding sites. Scatchard analysis of the binding data of FL cells revealed the presence of 5200 binding sites per cell and a Kd value of 2.1 X 10(-10) M. Although the binding of 125I ReINF-gamma was inhibited by unlabelled natural IFN-gamma and ReIFN-gamma, it was not inhibited by unlabelled human ReIFN-alpha and ReIFN-beta, suggesting that receptors for (Re)IFN-gamma were different from those for IFN-alpha or IFN-beta. However, ReIFN-gamma displaced the binding of 125I ReIFN gamma 3 to 5 times more effectively than IFN-gamma. Internalization of 125I ReIFN-gamma bound to the cell surface receptor was observed at 37 degrees C. Pretreatment of FL cells with unlabeled ReIFN-gamma caused a concentration-dependent down-regulation in the ReIFN-gamma receptor, which was specific for IFN-gamma and reversible. From these studies, we concluded that although the ReIFN-gamma is not identical to putative IFN-gamma, the recombinant form binds to the same binding sites for IFN-gamma and does not bind to the binding sites for IFN-alpha or beta.

Binding, Competitive↗